BRAIN FATTY ACID COMPOSITION AND THE ANESTHETIC EFFECT
脑脂肪酸组成与麻醉作用
基本信息
- 批准号:3293676
- 负责人:
- 金额:$ 17.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-12-01 至 1991-11-30
- 项目状态:已结题
- 来源:
- 关键词:anesthetics barbiturates brain metabolism convulsants drug metabolism drug tolerance eicosanoids essential fatty acids fatty acid metabolism general anesthesia halothane laboratory mouse laboratory rat linoleate lipid structure membrane structure neuropharmacology neurotransmitters nuclear magnetic resonance spectroscopy nutrition related tag opiate alkaloid oxidoreductase inhibitor phosphatidylinositols radiotracer
项目摘要
In previous work I have demonstrated that brain essential fatty acid
deficiency (EFAD) increases the sensitivity of rodents to a variety of
volatile anesthetics and decreases their sensitivity to the volatile
convulsant fluorothyl. Increased volatile anesthetic sensitivity was
specifically reversed by a parenteral supplementation protocol (linoleic
acid) that preferentially repleted the arachidonic acid content of cerebral
cortical polyphosphoinositides. I propose to study the molecular
mechanisms through which EFAD alters anesthetic/convulsant potency, and
thus to gain insight into the molecular mechanisms of volatile
anesthetic/convulsant action. To reach this goal, I propose three general
areas of study: (1) To pursue my preliminary observations by studying the
effects of brain EFAD and of volatile anesthetics/convulsants on the
neurotransmitter-stimulated generation of phosphoinositide derived chemical
second messengers (IP3, diacylglycerol, arachidonate metabolites). (2) To
further characterize the model by determining the effects of EFAD on the
potency of non-volatile anesthetics and convulsants and (3) To determine if
EFAD alters the chemical interaction between anesthetics/convulsants and
brain membranes using NMR spectroscopic techniques. The results of these
three areas of investigation should provide new insights concerning the
relationship(s) between whole animal anesthetic/convulsant effect, neuronal
chemical composition and specific biochemical and/or physicochemical
effects of anesthetics/convulsants.
在之前的工作中,我已经证明了大脑必需脂肪酸
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEX S. EVERS其他文献
ALEX S. EVERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEX S. EVERS', 18)}}的其他基金
Neurosteroid and Cholesterol Binding to Integral Membrane Proteins
神经类固醇和胆固醇与整合膜蛋白的结合
- 批准号:
10623887 - 财政年份:2023
- 资助金额:
$ 17.89万 - 项目类别:
Molecular Targets of Neurosteroid Anti-depressant Action
神经类固醇抗抑郁作用的分子靶点
- 批准号:
10198242 - 财政年份:2021
- 资助金额:
$ 17.89万 - 项目类别:
Molecular Targets of Neurosteroid Anti-depressant Action
神经类固醇抗抑郁作用的分子靶点
- 批准号:
10662406 - 财政年份:2021
- 资助金额:
$ 17.89万 - 项目类别:
Molecular Targets of Neurosteroid Anti-depressant Action
神经类固醇抗抑郁作用的分子靶点
- 批准号:
10456973 - 财政年份:2021
- 资助金额:
$ 17.89万 - 项目类别:
Characterization of the pH-sensing interface of the arenavirus envelope glycoprotein GPC
沙粒病毒包膜糖蛋白 GPC pH 传感界面的表征
- 批准号:
8985941 - 财政年份:2015
- 资助金额:
$ 17.89万 - 项目类别:
Characterization of the pH-sensing interface of the arenavirus envelope glycoprotein GPC
沙粒病毒包膜糖蛋白 GPC pH 传感界面的表征
- 批准号:
9089864 - 财政年份:2015
- 资助金额:
$ 17.89万 - 项目类别:
相似海外基金
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
6186427 - 财政年份:2000
- 资助金额:
$ 17.89万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2889982 - 财政年份:1999
- 资助金额:
$ 17.89万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2674540 - 财政年份:1998
- 资助金额:
$ 17.89万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2460299 - 财政年份:1997
- 资助金额:
$ 17.89万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2242968 - 财政年份:1997
- 资助金额:
$ 17.89万 - 项目类别:
ACUTE AND CHRONIC BARBITURATES--IN VITRO BIOCHEMISTRY
急性和慢性巴比妥酸盐——体外生物化学
- 批准号:
2118213 - 财政年份:1990
- 资助金额:
$ 17.89万 - 项目类别:














{{item.name}}会员




